10-K: FDCTech Reports Strong 2025 Growth and Profitability
Annual Report
FDCTech, Inc. achieved a return to profitability in fiscal year 2025 with $34.96 million in revenue and $5.78 million in net income.
Summary
- Total revenue increased 29.8% to $34.96 million in 2025, compared to $26.94 million in 2024.
- Net income attributable to shareholders was $5.78 million in 2025, a significant turnaround from the $18,781 loss in 2024.
- Operating income reached $6.05 million, compared to an operating loss of $0.90 million in the prior year.
- The company successfully acquired Alchemy International Ltd. (AIL) in 2025, expanding its regulatory footprint.
- Working capital improved to $14.88 million as of December 31, 2025, from $0.85 million in 2024.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive report due to the return to profitability and revenue growth, though the persistent material weaknesses in internal controls and reliance on related party transactions temper the outlook.
Positives
- Strong revenue growth of 29.8% year-over-year.
- Successful return to profitability with $5.78 million in net income.
- Significant expansion of the Technology & Software segment, with revenues up 210.5%.
- Elimination of accumulated deficit, reporting an accumulated surplus of $3.12 million.
- Improved operating leverage, with operating expenses growing only 1.1% despite 30% revenue growth.
Negatives
- Material weaknesses in internal control over financial reporting persist, including segregation of duties and U.S. GAAP expertise.
- Negative operating cash flow of $40.98 million, primarily due to a $35.8 million increase in related party receivables.
- Reliance on related party funding and intercompany arrangements.
- Ongoing legal proceedings, including a $1.02 million claim by former shareholders of Alchemy Markets Ltd.
Risks
- Geopolitical instability, specifically the U.S.-Israel-Iran conflict, which could impact operations and market volatility.
- Regulatory risks associated with operating in multiple jurisdictions (Malta, UK, Australia, Seychelles, Mauritius).
- Dependence on related party transactions and potential conflicts of interest.
- Cybersecurity threats to information systems and client data.
- Risks associated with the integration of acquired entities and the ability to realize expected synergies.
Future Outlook
The company intends to pursue an uplisting to a senior national securities exchange, such as the Nasdaq or NYSE, and is preparing a registration statement on Form S-1. Management expects continued growth in the Technology segment and aims to sustain profitability through its diversified platform.
Management Comments
- Management believes the current liquidity position is sufficient to fund operating and capital requirements for at least twelve months.
- Management expects the related party receivables to be substantially settled during fiscal year 2026.
- The company intends to convert all officers to employee status during the second quarter of 2026.
Industry Context
StockSavvy.ai notes that FDCTech is attempting to transition from a niche technology provider to a diversified global fintech platform. The company's reliance on acquisition-driven growth and intercompany funding is common in the OTC brokerage space but carries significant execution and regulatory risks.
Comparison to Industry Standards
- The company operates in a highly competitive market against established players like IG Group, Plus500, and Saxo Bank.
- The company's regulatory footprint is broad but requires significant compliance resources compared to larger, more established peers.
- The company's technology suite competes with established vendors like MetaQuotes and Spotware.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Action | Approval of authorized share increase and reverse stock split authorization. | 2025-09-04 | Provides flexibility for potential uplisting and capital raising. |
Legal Proceedings
- Asher Alkoby, et al. v. FDCTech (London Circuit Commercial Court)
- FDCTech, Inc. v. Intelligenceline.com, Fintelegram.com, et al. (Superior Court of California)
- Alchemy Markets Ltd. v. Il-Korp gall-Analizi ta Informazzjoni Finanzjarja (Malta Court of Appeal)
- Alchemy Markets Ltd. v. L-Avukat tal-Istat u Il-Korp gall-Analizi ta Informazzjoni Finanzjarja (Malta Constitutional Court)
Related Party Transactions
- Significant intercompany funding arrangements with Alchemy DMCC and Alchemy Capital Markets Ltd.
- Acquisition of Alchemy International Ltd. from SYNC Capital Limited, an entity controlled by Gope S. Kundnani.
- Issuance of Series B Preferred Stock to related parties for services and cash.
Stakeholder Impact
- Shareholders may face dilution from potential future equity offerings.
- The planned reverse stock split may impact share price and liquidity.
- The company's return to profitability is a positive indicator for creditors and investors.
Next Steps
- File an S-1 registration statement for a proposed public offering.
- Pursue uplisting to a senior national securities exchange.
- Convert officers to employee status in Q2 2026.
- Continue legal defense in ongoing litigation matters.
Key Dates
| Date | Description |
|---|---|
| 2016-01-21 | Company founded. |
| 2025-04-03 | Dismissal of Olayinka Oyebola & Co. and engagement of LAO Professionals. |
| 2025-09-04 | Board approval of authorized share increase and reverse stock split authorization. |
| 2025-10-29 | Acquisition of Alchemy International Ltd. (AIL) finalized. |
| 2025-12-31 | Fiscal year end. |
| 2026-02-28 | U.S. and Israel military strikes against Iran. |
| 2026-04-17 | Filing date of the 10-K. |
Recommendation
holdWhile the company has shown strong financial improvement and growth, the persistent material weaknesses in internal controls and the complexity of related party transactions suggest a cautious approach until the company successfully completes its planned uplisting and remediates its control environment.
Keywords
fintech, brokerage, wealth management, trading technology, FDCTech, OTC, financial services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.